To examine the role of MyoD1 in GC progression in vivo, we inoculated LV-MyoD1-MKN-45 and control cells into nude mice, respectively, and examined tumor distribution and size on the 21st day after injection. This evidence concerns the gene MYOD1 and neoplasm.